Laboratory compound raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-07-28. Anything still debated is marked as such rather than presented as settled.
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport | Listed by WADA as a PPARδ agonist. |
| Typical detection matrix | Urine | Most common sample for anti-doping analysis. |
| Common analytical method | LC-MS/MS | Liquid chromatography-tandem mass spectrometry. |
| Common synonyms | GW501516, GSK-516, endurobol | Names found in research and fitness contexts. |
| Typical detection window | Variable | Depends on dose, route, and individual metabolism. |
Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.
GW501516 acts as an agonist at the peroxisome proliferator-activated receptor delta, a nuclear receptor that regulates gene expression. Activation shifts transcription toward genes involved in fatty acid uptake, oxidation, and energy expenditure. The compound does not bind the androgen receptor and therefore differs from anabolic steroids and SARMs. In rodent models, this metabolic shift has been linked to increased running endurance and reduced fat accumulation. The exact downstream pathways in humans remain incompletely characterized.
Early clinical research explored GW501516 for lipid disorders, obesity, and diabetes. Some short-term human studies reported changes in HDL cholesterol, LDL cholesterol, and triglycerides. The development program was discontinued after rodent studies showed dose-dependent tumor formation in multiple tissues, including liver, bladder, stomach, and skin. These findings raised concerns about long-term cancer risk in humans. Because human exposure data are limited, the clinical significance of the rodent tumors remains uncertain.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.
Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.
== Regulatory history == The device was evaluated under an investigational device exemption in the United States, where it was compared against transforaminal lumbar interbody fusion. It was later granted FDA Breakthrough Device designation in 2021, followed by full FDA approval in 2023 after demonstrating superiority over fusion in composite clinical success. The TOPS System also holds CE marking, signifying that it meets health, safety, and environmental requirements for sale in the European Economic Area.
Acetyl-CoA carboxylase 1 (ACC1) Carbamoyl phosphate synthetase 1 (CPS1) Carnitine palmitoyltransferase 1 (CPT1) Enolase 1 (ENO1) Formyltetrahydrofolate dehydrogenase, 10- (ALDH1L1) Fructose bisphosphate aldolase B (ALDOB) Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) Histone H2B Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) Very long-chain acyl-CoA dehydrogenase (VLCAD)
=== Atlantic === The fish maw trade in Brazil has grown significantly since fishermen pivoted from the shark's fin trade; the Brazilian government banned shark finning in 2012, and has introduced other restrictions on shark fishing since. Between 2015 and 2018, Brazil was the largest exporter of fish maw to Hong Kong at 3,300 tonnes (3,600 short tons), valued at HK$3 billion; 95% of exported maws came from Para, Brazil. Brazilian export of fish byproducts, including fish maw, increased by 398% from 2012 to 2020; 97% of fish byproducts were exported to China in 2021. Mirroring worldwide trends, Sciaenidae maw fetches the highest price at market in Brazil; Ariidae maw, although being significantly larger, is frequently sold in unsorted bulk (Portuguese: ariru).
== Development == Prior to enamel formation, dentin formation begins through a process known as dentinogenesis, and this process continues throughout a person's life even after the tooth has fully developed. Events such as tooth decay and tooth wear can also initiate dentin formation. Dentinogenesis is initiated by the odontoblasts of the pulp. Odontoblasts are specialised cells that lay down an organic matrix known as pre-dentin. This predentin is subsequently mineralized into dentin. Mineralization of predentin begins at the dentinoenamel junction during tooth development and progresses towards the pulp of the tooth. After growth of predentin and maturation into dentin, the cell bodies of the odontoblasts remain in the pulp, along its outer wall, and project into tiny tubules in the dentin. Predentin is composed of 90% type I collagen and 10% non-collagenous proteins (including phosphoproteins, proteoglycans, growth factors, phosphatases such as alkaline phosphatase, and matrix metalloproteinases (MMPs)), and this composition is significantly altered when it is mineralized into dentin. See the Structure section for information about the composition of dentin.
== History == Founded in 1997 to produce contractual mods for state of the art 3D game engines, Black Widow Games would release 14 games between their first mod, Soldier Of Fortune (created for Rysher Entertainment), and 2003. Notable releases included the Half Life spin-off, USS Darkstar (produced for PC Gamer), and the They Hunger series (produced for PC Gamer). They Hunger in particular generated extensive player discussion and was considered an example of good gameplay within the realm of Half-Life mods. To promote the 2003 film Underworld, Sony Pictures commissioned Black Widow Games a promotional tie-in mod titled Underworld: Bloodline. The mod was available on Sony Pictures' official website until the end of 2007 and remains the only officially licensed Half-Life mod tied to a Hollywood film. In October 2005, the company declared it was not possible anymore to produce full-fledged single player mods working on low budget promotional projects within reduced development cycles, because of the higher level of detail required for modern 3D engines. At this time, the company revealed it had been secretly developing for almost a year its first commercial game They Hunger: Lost Souls, based on the Half-Life 2 Source engine, a successor to their popular Half-Life survival horror mod, They Hunger, which Black Widow Software had created in 1999 and released as a bonus with copies of the PC Gamer magazine. It would feature a plotline revolving around a zombie outbreak in northeastern Europe in the 1960s.
Sources: en.wikipedia.org
Critics such as Noam Chomsky argue continuing research into symbolic AI will still be necessary to attain general intelligence, in part because sub-symbolic AI is a move away from explainable AI: it can be difficult or impossible to understand why a modern statistical AI program made a particular decision. The emerging field of neuro-symbolic artificial intelligence attempts to bridge the two approaches.
Bryant, Chad (2009). Prague in Black Nazi Rule and Czech Nationalism. Harvard University Press: Cambridge. ISBN 978-0-674-26166-2. Gruner, Wolf (2015). "Protectorate of Bohemia and Moravia". The Greater German Reich and the Jews: Nazi Persecution Policies in the Annexed Territories 1935–1945. War and Genocide. Berghahn Books. pp. 99–135. ISBN 978-1-78238-444-1. Mahoney, William (2011), The History of the Czech Republic and Slovakia, Santa Barbara: Greenwood Publishing Group, ISBN 978-0-313-36305-4 Miller, Daniel (2005). "The Czech Republic". In Richard C. Frucht (ed.). Eastern Europe An Introduction to the People, Lands, and Culture. Santa Monica: ABC-CLIO. pp. 203–283. ISBN 978-1-57607-800-6. Murray, Williamson (1984). The Change in the European Balance of Power, 1938–1940. Princeton: Princeton University Press. Overy, Richard (1999). "Germany and the Munich Crisis: A Multilated Victory?". In Igor Lukes & Erik Goldstein (ed.). The Munich Crisis, 1938, Prelude to World War II. London: Frank Cass. pp. 191–215. ISBN 0-7146-8056-7. Rothwell, Victor (2001). The Origins of the Second World War. Manchester: Manchester University Press. ISBN 978-0-7190-5958-2. Tooze, Adam (2006). The Wages of Destruction The Making and Breaking of the Nazi Economy. London: Allan Lane. ISBN 978-0-7139-9566-4.
=== Physical characteristics === Diallyl disulfide has a strong garlic smell. It is a clear, yellowish liquid which boils at 138–139 °C (for the typical 80% purity) and has its flash point at 50 °C, a density of about 1.0 g/mL and a vapor pressure of 1 mmHg at 20 °C. It is non-polar; therefore, diallyl disulfide is insoluble in water and is soluble in fats, oils, lipids, and non-polar solvents such as hexane or toluene.
Early in 1953 Watson and Crick proposed a correct structure for the DNA double helix. Pauling later cited several reasons to explain how he had been misled about the structure of DNA, among them misleading density data and the lack of high quality X-ray diffraction photographs. Pauling described this situation as "the biggest disappointment in his life". During the time Pauling was researching the problem, Rosalind Franklin in England was creating the world's best images. They were key to Watson's and Crick's success. Pauling did not see them before devising his mistaken DNA structure, although his assistant Robert Corey did see at least some of them, while taking Pauling's place at a summer 1952 protein conference in England. Pauling had been prevented from attending because his passport was withheld by the State Department on suspicion that he had Communist sympathies. This led to the legend that Pauling missed the structure of DNA because of the politics of the day (this was at the start of the McCarthy period in the United States). Politics did not play a critical role. Not only did Corey see the images at the time, but Pauling himself regained his passport within a few weeks and toured English laboratories well before writing his DNA paper. He had ample opportunity to visit Franklin's lab and see her work, but chose not to. Despite these times, Pauling chose to move on from them and be thankful for the discoveries that he had already found.
In the United States, it also operates under the Speedway brand (predominantly in the Midwest and on the East Coast) and as Stripes Convenience Stores within the West South Central states. Both Speedway and Stripes operate alongside 7-Eleven's namesake stores in several American markets. 7-Eleven also operates A-Plus locations, licensing the name from its owner, Energy Transfer Partners, a fellow company based in the Dallas–Fort Worth metroplex. However, most of these stores have since been rebranded as standard 7-Eleven stores.
Sources: en.wikipedia.org
Yes, WADA prohibits cardarine as a PPARδ agonist. It appears on the prohibited list and can be detected in urine or blood. Athletes using it risk sanctions.
Detection usually uses liquid chromatography-tandem mass spectrometry after sample cleanup. Laboratories look for the parent compound or metabolites. The method requires validated reference standards and controls.
Legality varies by country. In many places it is an unapproved drug and cannot be legally sold for human consumption. Purchasing from online vendors carries legal and quality risks.
It binds and activates PPARδ, a nuclear receptor that influences gene expression related to fatty acid metabolism and energy balance. This mechanism has been studied mainly in animals and cell models, not established as a safe human therapy.